Balance Sheet

Currency: EUR

	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	1	3	14	15	14	16	29	22	19	16
Cash	1	3	14	15	14	16	29	22	19	16
Cash Equivalents	0	0	0	0	0	0	0	0	0	0
Short-Term Investments	0	0	0	1	5	4	5	5	6	13
Total Receivables	8	9	10	15	16	17	18	24	23	24
Accounts Receivables	8	9	10	13	15	15	17	22	19	22
Other Receivables	0	0	0	2	1	2	1	2	3	2
Inventory	1	1	2	2	2	2	3	5	8	7
Other Current Assets	0	0	0	2	1	1	1	3	3	5
Total Current Assets	10	13	27	34	37	40	56	59	59	65
PP&E Net	1	1	1	1	5	5	8	17	26	26
PP&E Gross	1	1	1	1	5	5	8	17	26	26
Accumulated Depreciation	0	1	1	1	2	2	3	3	5	6
Intangible Assets	2	1	2	2	2	2	3	4	5	6
Goodwill	1	3	3	3	3	3	3	18	18	18
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	1	0	1	1	2	1	2	3	5	3
Other Assets	1	3	3	3	3	3	3	18	18	18
Total Assets	15 N/A	19 +24%	33 +76%	41 +24%	49 +18%	52 +6%	71 +38%	100 +40%	112 +12%	117 +4%
Liabilities
Accounts Payable	3	4	5	6	8	6	8	15	14	13
Accrued Liabilities	0	2	2	2	3	2	2	3	3	4
Short-Term Debt	1	2	1	1	1	1	0	0	1	0
Current Portion of Long-Term Debt	2	1	1	2	4	0	1	4	4	4
Other Current Liabilities	1	1	1	1	1	1	5	4	6	5
Total Current Liabilities	7	10	10	13	16	11	17	26	28	27
Long-Term Debt	3	2	3	2	2	1	6	14	23	20
Minority Interest	0	0	0	0	0	0	0	0	0	0
Other Liabilities	1	1	2	2	3	2	4	9	7	8
Total Liabilities	11 N/A	12 +10%	14 +16%	17 +19%	21 +22%	14 -33%	26 +88%	49 +87%	58 +18%	55 -5%
Equity
Common Stock	0	0	1	1	1	1	1	1	1	1
Retained Earnings	4	6	18	23	27	37	44	52	57	66
Treasury Stock	0	0	0	0	0	0	0	2	4	5
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	4 N/A	7 +62%	19 +187%	24 +28%	28 +15%	38 +34%	45 +19%	51 +13%	54 +7%	62 +14%
Total Liabilities & Equity	15 N/A	19 +24%	33 +76%	41 +24%	49 +18%	52 +6%	71 +38%	100 +40%	112 +12%	117 +4%
Shares Outstanding
Common Shares Outstanding	7	7	10	10	10	10	10	10	10	10

Pharmanutra SpA
MIL:PHN